New element order is copied to your clipboard. Please paste it in the Element order variable.
2

  

COVID-19 Rapid Antigen Testing
Solutions for Professional Use

Roche solutions offer a fast and effective way to help
protect businesses from COVID-19, enabling further
confidence in a COVID-19 Safety Plan.

REGISTRATION
3
4

The COVID-19 Rapid Antigen Self-Test (for home use) is intended for unsupervised testing in the home or other environment.
The COVID-19 Rapid Antigen Point of Care (POC) tests (for professional use) are intended for use at the point of care and must be used by relevant practitioners, or persons under their supervision, who are trained in the correct use of the goods and the interpretation of the test results. These tests must not be supplied for the purpose of self-testing.
Negative test results do not exclude infection with COVID-19 (so face masks, social distancing and good hygiene practice must be maintained).
Follow current government health messaging regarding polymerase chain reaction (PCR) testing requirements.

5

To watch the video, please allow targeting cookies by clicking here!

Roche is deeply committed to supporting the global response to put an end to the COVID-19 pandemic. Testing is a critical part in fighting this unprecedented global healthcare emergency and we are proud to be able to contribute.

Our rapid testing solutions not only add a layer of confidence to your employees but can act as part of a risk mitigation strategy to protect your business continuity and help keep your business running. 

Protect your workforce and maximise productivity. Talk to us today about how we can help your COVID-19 Safety Plan.
Request a Call
6





To watch the video, please allow targeting cookies by clicking here!



Roche’s response to the COVID-19 pandemic

We are deeply committed to supporting the global response to put an end to the COVID-19 pandemic. Testing is a critical part in fighting this unprecedented global healthcare emergency and we are proud to be able to contribute.


7

To watch the video, please allow targeting cookies by clicking here!

 

Roche tests able to detect
new Omicron variant

Roche can confirm our PCR, antibody and antigen tests can detect the new Omicron virus variant. To view the full list of tests click here.
Get in Touch
8

Rapid testing types provided by Roche

To find out more, request a callback or download the brochure.


Help protect your business with a COVID-19 rapid testing solution from Roche

9

To watch the video, please allow targeting cookies by clicking here!
Download the Brochure
Request a call
10
11
12
13
14

Our Rapid Testing Solutions

 
SARS-CoV-2 Rapid Antigen Test
Included on the ARTG (ID:352250)
Testing ready to go when you need to know
SARS-CoV-2 Rapid Antigen Test allows for decentralised testing and enables fast decision making in diverse settings.
Download the Brochure

 
SARS-CoV-2 Antigen Self Test Nasal
Included on the ARTG (ID:352250)
Available now for self-testing
Reliable SARS-CoV-2 antigen test results in just 15 minutes for unsupervised testing in the home or other environment.
Download the Brochure

 
NAVIFY® Pass Solution

An end-to-end digital COVID-19 Solution
NAVIFY® Pass aids test providers and recipients to share diagnostic results securely, remotely and seamlessly.
Download the Brochure
Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing amet

15
Contact our experts for further information and learn how to add testing to your COVID-19 Safety Plan today.
18

COVID-19 Scientific Webinar Series

1st Webinar
Coagulopathy in COVID-19
15:00 - 16:15 CET
Welcome and introduction
Prof. Nicole Juffermans
Thrombotic and haemostatic issues in intensive care, which challenges do we face and what the biomarkers tell us
13:30-13:45
Prof. Edwin J.R. van Beek
Role of Radiology and plasma D-dimer in pathophysiological aspects and treatment of COVID-19
13:30-13:45
Dr. Michelle Sholzberg
Anticoagulation & therapeutic management :
Which treatment fits best and how can we monitor?
13:30-13:45
Q& session
2nd Webinar
Lorem ipsum 08 July 2020
15:00 - 16:15 CET
Welcome and introduction
Prof. James Januzzi
Is a member of the Massachusetts General Hospital Cardiology Division. He is the Hutter Family Professor of Medicine at Harvard Medical School and is on faculty at the Harvard Clinical Research Institute
13:30-13:45
Dr. Raphael Twerenbold
Is an interventional cardiologist and senior physician at the Clinic for Cardiology at the University Hospital Basel
13:30-13:45
Prof. Alexandre Mebazaa
Is Professor of Anaesthesiology and Critical Care Medicine at the Hôpital Lariboisière, University Paris 7, France
13:30-13:45
Dr. Zhou Ning
Associate Professor, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
13:30-13:45
Q& session
3rd Webinar
Lorem ipsum 14 July 2020
15:00 - 16:15 CET
Welcome and introduction
W. Conrad Liles
MD, PhD, University of Washington, Seattle, US
13:30-13:45
Tobias Weinberger
MD, Ludwig Maximilian University of Munich, Munich, Germany
13:30-13:45
Q& session
4th Webinar
Lorem ipsum 16 July 2020
15:00 - 16:15 CET
Welcome and introduction
Prof. Anna Kajdy
Head of Obstetrics Department, St. Sophie's Obstetrics and Gynecology Hospital, Warsaw, Poland
13:30-13:45
Prof. Liona Poon
Clinical Professor, Obstetrics, CUHK, Hong Kong
13:30-13:45
Q& session